Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation (ADPT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
adpt · stock forecast · 17 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 17 Wall Street analysts in the past 3 months
Buy
17 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$22.00
Consensus
$21.33
+27.1% upside
Low
$21.00
Median: $21 · Last Close: $16.79
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$21.33
27.1% upside
High Target
$22
31.1%
Low Target
$21
25.1%
Current Price
$16.79
as of today
Based on analyst price targets, the ADPT stock price prediction for the next 12 months ranges from $21 to $22. The consensus ADPT price forecast of $21.33 implies 27.1% upside from the current price of $16.79.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $17.62 | ↑ 5.00% |
1-day model range: $17.48–$17.77. Peak: $17.77 (+5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $17 | +0.2% |
| 2028 | $17 | +0.3% |
| 2029 | $17 | +0.4% |
| 2030 | $17 | +0.4% |
| 2031 | — | +0.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ADPT · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-12 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2026-05-06 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-06 | TD Cowen | Maintains | Buy→Buy |
| 2026-05-06 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-05-06 | BTIG | Maintains | Buy→Buy |
| 2026-02-06 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-02-06 | BTIG | Maintains | Buy→Buy |
| 2026-01-26 | Guggenheim | Maintains | Buy→Buy |
| 2025-11-11 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2025-11-06 | BTIG | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Adaptive Biotechnologies Corporation (ADPT) stock. Of the recent 81 rating actions, 4 were upgrades and 11 were downgrades. 17 analysts currently cover ADPT.
Analyst Recommendation Trends
ADPT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 4 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$286M
↓ 33.1% YoY
Revenue Next Year
$350M
↑ 22.4% YoY
EPS This Year
$-0.46
EPS Next Year
$-0.25
↓ 46.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast ADPT EPS of $-0.46 for the current fiscal year, based on estimates from 6 analysts. The ADPT revenue forecast is $286M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ADPT stock forecast is supported by two independent data sources: analyst consensus ratings from 17 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ADPT price target is $21.33 (+27.1% upside), with an analyst consensus of Buy.
The ADPT short-term stock prediction for tomorrow is $17.62 (+5.00%). The ADPT stock price prediction for 2027 estimates an average of $17. The ADPT stock prediction for 2030 projects a range of $15–$18.
Adaptive Biotechnologies Corporation trades on NASDAQ under the ticker ADPT. The ADPT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 65% of covering analysts.
Frequently asked questions
ADPT forecast · 8 questionsAccording to 17 Wall Street analysts, the average 12-month ADPT price target is $21.33, with a high forecast of $22.00 and a low of $21.00. The median price target is shown in the chart above when available. This implies +27.1% potential upside from the current price of $16.79.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.